Alexza

Alexza Pharmaceuticals is an emerging specialty pharmaceutical company dedicated to the development and commercialization of novel proprietary products for the treatment of acute and intermittent conditions.Alexza Pharmaceuticals' product and development pipeline is based on the Staccato system—a handheld inhaler designed to deliver pure drug aerosols to the lungs, providing rapid systemic delivery and onset of therapy in a simple, non-invasive manner.Alexza Pharmaceuticals' pipeline product candidates include: AZ-002 (Staccato alprazolam) for the treatment of seizures in patients with acute repetitive epilepsy, AZ-003 (Staccato fentanyl) for cancer breakthrough pain, and AZ-007 (Staccato zaleplon) for the treatment of moderate insomnia in patients during the night.